about
Gold nanoparticles for biology and medicine.Tailoring DNA structure to increase target hybridization kinetics on surfaces.Scavenger receptors mediate cellular uptake of polyvalent oligonucleotide-functionalized gold nanoparticles.Using DNA to Link Gold Nanoparticles, Polymers and Molecules: a Theoretical Perspective.Strategy for increasing drug solubility and efficacy through covalent attachment to polyvalent DNA-nanoparticle conjugates.Tris(benzimidazolyl)amine-Cu(II) coordination units bridged by carboxylates: structures and DNA-condensing property.Ratiometric detection of oligonucleotide stoichiometry on multifunctional gold nanoparticles by whispering gallery mode biosensing.Rational design of gold nanocarrier for the delivery of JAG-1 peptide.Bioresponsive antisense DNA gold nanobeacons as a hybrid in vivo theranostics platform for the inhibition of cancer cells and metastasis.Quantification and real-time tracking of RNA in live cells using Sticky-flaresAntibody-linked spherical nucleic acids for cellular targetingBeauty is skin deep: a surface monolayer perspective on nanoparticle interactions with cells and bio-macromolecules.Inactivation of expression of several genes in a variety of bacterial species by EGS technology.Controlled delivery of antisense oligonucleotides: a brief review of current strategies.Gold nanoparticle probes for the detection of mercury, lead and copper ions.Cellular uptake, intracellular trafficking, and cytotoxicity of nanomaterials.Radiolabeled oligonucleotides for antisense imaging.Monolayer coated gold nanoparticles for delivery applicationsGold nanomaterials: preparation, chemical modification, biomedical applications and potential risk assessment.Gold nanoparticle conjugates: recent advances toward clinical applications.Tracking the down-regulation of folate receptor-α in cancer cells through target specific delivery of quantum dots coupled with antisense oligonucleotide and targeted peptide.Nano-flares for mRNA regulation and detection.Aptamer nano-flares for molecular detection in living cellsNanomaterial-based biosensors using dual transducing elements for solution phase detection.Targeted delivery of antisense oligonucleotides by chemically self-assembled nanostructures.Functionalized Gold Nanoparticles and Their Biomedical Applications.Precisely tailored DNA Nanostructures and their Theranostic Applications.Regulating immune response using polyvalent nucleic acid-gold nanoparticle conjugates.Tailoring of biomimetic high-density lipoprotein nanostructures changes cholesterol binding and efflux.Cellular response of polyvalent oligonucleotide-gold nanoparticle conjugates.Preparation of stable maleimide-functionalized au nanoparticles and their use in counting surface ligands.Gold nanoparticles functionalized with a fragment of the neural cell adhesion molecule L1 stimulate L1-mediated functions.Measuring and modelling cell-to-cell variation in uptake of gold nanoparticles.Nanobarcoded superparamagnetic iron oxide nanoparticles for nanomedicine: Quantitative studies of cell-nanoparticle interactions by scanning image cytometry.Engineering nucleic acid structures for programmable molecular circuitry and intracellular biocomputation.The promising potentials of capped gold nanoparticles for drug delivery systems.Liposomal Spherical Nucleic Acids for Regulating Long Noncoding RNAs in the Nucleus.Efficient, pH-triggered drug delivery using a pH-responsive DNA-conjugated gold nanoparticle.Functionalized Gold Nanoparticles for the Detection of C-Reactive Protein.
P2860
Q33558781-3C0076EF-490A-42D7-A560-762626037C71Q33648421-2C4CC034-44FD-474B-BDB8-F2932BD66F5EQ33744219-DC53662F-E945-44FF-BF1D-A1A164C4B7B8Q33947552-AAADE242-55E2-4EB2-A8D8-660FB3063CC2Q33980411-6EF910BC-CB57-4186-BAB4-CAB0EC724BA7Q34052028-229873D4-45E1-4FAA-9376-6DF9C19B4581Q35582027-A7AD91AE-3D17-41C7-B918-EC741AC3CC92Q35748112-7DE1D225-0840-4828-9802-1E076B691DFEQ35865494-04616B2F-9872-4749-B40E-81367B799640Q35946076-C02351A6-FF94-46A7-8589-44753DC33B8EQ36408634-2AB04297-0527-4280-84FE-CF9151FAE0DFQ36452638-AA507CC6-6BC9-4720-A367-39929D490934Q37208638-686D9C71-617F-4444-90EC-B00F03AABEEBQ37529859-F3BD6B7B-60BC-42F4-828A-3C6F364EC007Q37820905-0C6F12F6-B18B-4EBE-9713-056CD03C6DDBQ37869062-D2D5FC9F-CC15-4BC7-AB59-B4C7D466ACA4Q37913042-83AD10ED-CA9C-4DE5-9577-57C8730B2F16Q37934050-65A7194A-E49A-4C59-BC5D-D2933F3F0264Q37978752-ABC38FE4-6459-4E19-9D5F-C53CD5CB9888Q38190087-83EAD1C8-3246-4D26-AC27-A3AEE490F934Q38314361-3C991CEF-B0CF-46D9-9084-5331C472DC62Q38351198-78874654-35FD-4D71-BC75-887CE95E0323Q38351820-9F42FD81-B68F-42BE-AF21-B8C4E22D2C39Q38374911-FF2925C2-D98C-49B9-A0EF-DD474986D1BFQ39129886-BA54CFEB-D832-42D6-8A6A-24DC69B90422Q39203522-6F6E4DB2-199C-4623-8EBF-4EECA968B254Q39368893-9AB78CD2-9074-4D0C-BE98-FFB87121049DQ39790438-3B02C87C-1BDF-4458-81E3-5C88F622A4F0Q40577766-6E7E543E-0C7A-4DFF-A70F-817428FBF1B5Q41819990-950FFCE1-9C92-4F1E-AD75-3D1BBC1D913BQ43058839-D5C4A5FC-6D42-4271-89A8-1362E4F0DC3EQ43807816-95AF7103-FEB2-43ED-9E77-799F9C9DE0E8Q45184081-B8ABDE0A-8144-4525-AE50-EA1DF854A320Q46723706-CB05E7DA-56AF-4DB0-A470-7026E4AA491DQ47416347-4AA2673E-10F1-49D0-94EF-6FA0FCBEFB92Q47708024-9B81C424-7FBD-469E-B575-C5E74E0D43A2Q48887906-A786DEBB-6965-472B-A0D6-EE082B8179BEQ52842256-79A3E7F7-14C7-4FF4-8647-1BDFA33F6CB4Q55385902-77F48ACD-550B-4F83-8B09-297710889018
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Peptide antisense nanoparticles.
@ast
Peptide antisense nanoparticles.
@en
type
label
Peptide antisense nanoparticles.
@ast
Peptide antisense nanoparticles.
@en
prefLabel
Peptide antisense nanoparticles.
@ast
Peptide antisense nanoparticles.
@en
P2860
P356
P1476
Peptide antisense nanoparticles.
@en
P2093
David A Giljohann
Pinal C Patel
P2860
P304
17222-17226
P356
10.1073/PNAS.0801609105
P407
P577
2008-11-01T00:00:00Z